Glioma
- Primary brain tumours in adults (Lancet, October 2023)
- EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood (Nature Reviews Clinical Oncology, December 2020 + update March 2022)
Non-glioma
- Upfront Radiosurgery vs a Wait-and-Scan Approach for Small- or Medium-Sized Vestibular Schwannoma (Jama, August 2023)
- EANO guideline on the diagnosis and treatment of vestibular schwannoma (Neuro-Oncology, January 2020)
Re-irradiation
Re-irradiation
- To be added
- Radiotherapy Alone for Early-Stage Squamous Cell Carcinoma of the Larynx and Hypopharynx (Int. J. Radiation Oncology Biol. Phys., October 2007)
- Radiotherapy for early glottic carcinoma (T1N0M0): Results of prospective randomized study of radiation fraction size and overall treatment time (Int. J. Radiation Oncology Biol. Phys., January 2006)
- Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891 (Ann Oncol., October 2012)
- Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets (Semin Radiat Oncol., July 2002)
- Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines (Radiother Oncol., January 2018)
- Does 5 + 5 Equal Better Radiation Treatment Plans in Head and Neck Cancers? (Advances in Radiation Oncology, October-December 2019)
- Target delineation for postoperative treatment of head and neck cancer (Oral Oncol., November 2018)
- Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines (Radiother Oncol., January 2014)
- To be added
Lung cancer staging
- Rusch et al. The IASLC Lung Cancer Staging Project. A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer. JTO 2009;4(5):568-77.
- Silvestri et al. Methods for Staging Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2013;143(5)(Suppl):e211S-e250S.
- Detterbeck et al. The Eighth Edition Lung Cancer Stage Classification. Chest 2017;151(1):193-203.
General treatment guidelines
- https://www.esmo.org/guidelines/esmo-clinical-practice-guidelines-lung-and-chest-tumours
- https://www.nccn.org/professionals/physician_gls/
- Postmus et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017; 28 (Supplement 4): iv1-iv21.
Radiation therapy guidelines
- De Ruysscher et al. European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer. Radiother Oncol 2017;124:1-10.
- Nestle et al. ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer. Radiother Oncol 2018;127:1-5
- Guckenberger et al. ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early-stage non-small cell lung cancer. Radiother Oncol 2017;124:11-17
- Peeters et al. Selective mediastinal node irradiation in non-small cell lung cancer in the IMRT/VMAT era: how to use E(B)US-NA information in addition to PET-CT for delineation? Radiother Oncol 2016;120(2):273-8.
- Hanna et al. UK consensus on normal tissue dose constraints for stereotactic radiotherapy SABR dose constraints. Clin. Oncol (R Coll Radiol.) 2018;30(1):5-14
- Milo et al. Delineation of whole heart and substructures in thoracic radiation therapy: national guidelines and contouring atlas by the Danish Multidisciplinary Cancer Groups. Radiothérapie Oncol 2020; 150:121-127
- Kong et al. Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int J Radiat Oncol Biol Phys 2011;81:1442-57
- Feng et al. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2011;79:10-18
- Duane et al. A cardiac contouring atlas for radiotherapy. Radiother Oncol 2017;122:416-422
- https://www.ilrog.org/guidelines
- https://www.esmo.org/guidelines/haematological-malignancies
- The conundrum of Hodgkin Lymphoma nodes: To be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines (Radiotherapy & Oncology, August 2008)
- Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines (Radiotherapy & Oncology, June 2006)
- Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG) (IJROBP, July 2014)
- Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines (IJROBP, August 2020)
- To be added
Neuroblastoma
Late effects
- PEdiatric Normal Tissue Effects in the Clinic (PENTEC) (full issue)
- PanCare Guidelines Group. PanCareFollowUp Recommendations for long-term follow-up care of childhood, adolescent and young adult cancer survivors. 2024. Available at: www.pancare.eu.
- Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers
(https://www.survivorshipguidelines.org/ – October 2023)
- To be added
- To be added
- To be added
Re-irradiation
- Salvage brachytherapy for recurrent prostate cancer after radiotherapy: An expert-endorsed review by uroGEC (Radiotherapy & Oncology, September 2025)
- Salvage brachytherapy for local recurrence of cancer after definitive irradiation: a GEC-ESTRO narrative review (Radiotherapy & Oncology, August 2025)
- Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study (Radiotherapy & Oncology, July 2023)
- Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiation (ctRO, September 2024)
Bladder cancer
